NBIX — Neurocrine Biosciences, Inc.
10 mentions in the last 24 hours · 0.05% of all mentions
Why people talked about NBIX (2026-11-03)
- Neurocrine Biosciences reported Q3 2026 financial results with revenue of $1.1B and EPS of $6.92, both exceeding estimates.
- The company announced these financial results for the quarter ended September 30, 2026, via Form 8-K.
| Bluesky | 4 | community |
| GDELT | 2 | news |
| Marketaux | 1 | news |
| Press Wires (PRN/GNW/BW) | 1 | press |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |